MMA
Miracle Mile Advisors’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-4,938
| Closed | -$232K | – | 638 |
|
|
2024
Q3 | $232K | Sell |
4,938
-110
| -2% | -$5.17K | 0.01% | 474 |
|
|
2024
Q2 | $273K | Hold |
5,048
| – | – | 0.01% | 423 |
|
|
2024
Q1 | $344K | Hold |
5,048
| – | – | 0.01% | 387 |
|
|
2023
Q4 | $316K | Hold |
5,048
| – | – | 0.01% | 387 |
|
|
2023
Q3 | $229K | Hold |
5,048
| – | – | 0.01% | 437 |
|
|
2023
Q2 | $283K | Hold |
5,048
| – | – | 0.01% | 428 |
|
|
2023
Q1 | $228K | Hold |
5,048
| – | – | 0.01% | 461 |
|
|
2022
Q4 | $205K | Hold |
5,048
| – | – | 0.01% | 470 |
|
|
2022
Q3 | $330K | Buy |
+5,048
| New | +$330K | 0.02% | 345 |
|
|
2021
Q4 | – | Sell |
-3,501
| Closed | -$392K | – | 451 |
|
|
2021
Q3 | $392K | Buy |
3,501
+110
| +3% | +$12.3K | 0.02% | 325 |
|
|
2021
Q2 | $549K | Buy |
+3,391
| New | +$549K | 0.03% | 249 |
|